Growth focus Riverside Partners targets growth-oriented healthcare and technology companies in North America with EBITDA of $3-15M, indicating potential cross-sell of scaling and operational optimization solutions, revenue cycle enhancements, and technology implementations to accelerate expansion.

Portfolio expansion Recent activity includes acquisitions and platform-building through portfolio companies such as UnisLink, HST, and Christianbook, suggesting opportunities to engage with portfolio companies at various stages for add-on services, integration projects, and strategic acquisitions support.

Founder-friendly The firm positions itself as a founder-friendly, operationally-focused investor, which signals receptiveness to value-creation partnerships, change-management services, and governance or interim leadership engagements to drive growth in portfolio companies.

Tech and healthcare Specialization in technology and healthcare sectors aligns with modern digital transformation needs, offering opportunities for software modernization, data analytics, revenue cycle optimization, and regulatory/compliance tooling tailored to portfolio targets.

Established cap table With a 1989 founding and a mid-market footprint, Riverside has a long-standing network and potential access to co-investors, strategic buyers, and exit channels, enabling targeted outreach for strategic partnerships, liquidity events, or secondary opportunities.